Pfizer faces scrutiny over scale of Covid profits
Pfizer has won plaudits for its Covid vaccine delivery programme, but the US multinational faces growing scrutiny over the scale of its profits and the proportion of doses it has delivered to low-income countries, The Guardian reported.While ...